Serratia marcescens is a common pathogenic bacterium that can cause infections in both humans and animals. It can cause a range of diseases, from slight wound infections to life-threatening bacteraemia and pneumonia. The emergence of antimicrobial resistance has limited the treatment of the diseases caused by the bacterium to a great extent. Consequently, there is an urgent need to develop novel antimicrobial strategies against this pathogen. Synergistic strategy is a new approach to treat the infections caused by drug-resistant bacteria. In this paper, we isolated and identified the first multi-resistant pathogenic Serratia marcescens strain from diseased soft-shelled turtles (Pelodiscus sinensis) in China. We then performed a checkerboard assay; the results showed that out of 10 tested natural products fisetin had synergistic effects against S. marcescens when combined with norfloxacin. The time-kill curve assay further confirmed the results of the checkerboard assay. We found that this novel synergistic effect could significantly reduce the dosage of norfloxacin against S. marcescens.
INTRODUCTION
Serratia marcescens, a gram-negative bacillus belonging to the Enterobacteriaceae family, occurs widely in the natural environment. The organism was first considered as a non-pathogenic organism and extensively used as a biological marker because it could be easily recognized by the red color (Lin et al. 2014) . Furthermore, researchers have found that strains of S. marcescens can be used in the biodegradation of pentachlorophenol and pulp paper mill effluent (Wongsa et al. 2004; Singh et al. 2008 Singh et al. , 2009 ). However, cases of infections have been reported since 1951 and bacteraemia was first recorded in 1968. Therefore, it was known as an opportunistic pathogen that was related to several diseases both in humans and animals (Hejazi and Falkiner 1997) . It could cause a variety of diseases, including mastitis, urinary tract infection, wound infections and pneumonia, that threatened human health (Cox 1985; Gouin et al. 1993) . Antibiotics play an important role in the battle against infections caused by S. marcescens. However, it was reported that S. marcescens strains were resistant to a large number of antibiotics, including β-lactam, aminoglycoside and fluoroquinolone (Ishii et al. 2012; Yang et al. 2012) .
Currently, fluoroquinolones, which have a broad-spectrum activity against infections caused by bacteria, have been widely used in aquaculture in China and this has resulted in an increasing emergence of fluoroquinolone-resistant strains (Yang et al. 2012) . Because of the appearance of resistance, the therapies using antibiotics are limited. Therefore there is an urgent need to develop new strategies against this organism. Combination therapy is a novel strategy and maybe useful in the treatment of infections caused by drug-resistant strains of S. marcescens.
In this paper, we isolated a pathogenic strain of S. marcescens from the soft-shelled turtle (Pelodiscus sinensis) in Hubei, China. Biochemical and phylogenetic analyses were performed to determine the taxonomic position of the strain. Furthermore, the sensitivity of the strain to antibiotics was examined using the Kirby-Bauer disk diffusion method, and the synergistic effects of 10 natural products isolated from Chinese herb medicines, combined with norfloxacin which is extensively used in aquaculture in China, were tested. According to the results, we found that fisetin could be a potential drug in the control of drug-resistant S. marcescens infections.
MATERIALS AND METHODS

Micro-organisms and reagents
Bacteria strains were isolated from the livers of diseased softshelled turtles in Hubei, China, with typical symptoms of infection according to a previous report (Cao et al. 2010) . Natural products and norfloxacin (purity > 98%) were purchased from the National Institutes for Food and Drug Control (Beijing, China). Stock solutions of the agents at a concentration of 40 960 μg mL 
Identification of S. marcescens
The strain was firstly determined by biochemical assay using API 20E strips (BioMérieux SA, Marcy l'Etoile, France) in the ATB 32GN system. Briefly, the strain was cultured on LB agar plates at 28
• C for 18-24 h, then single clones of the strain were resuspended and loaded on an API 20E strip according to the manufacturer's instructions. The strips were incubated at 28
• C for 24 h. The biochemical characterization was determined according to the API identification index and database. For phylogenetic analysis, 16S rRNA of the isolate was amplified using polymerase chain reaction. After sequencing, the 16S rRNA of the strain was identified using the basic local alignment search tool (BLAST) program (Altschul et al. 1990 ).
Antibiotic susceptibility assay
The susceptibility of the strain to 16 antibiotics was determined using the Kirby-Bauer disk diffusion method. After incubation for 18-24 h, the diameters of the inhibition zones were measured. Then the susceptibility was determined according to the method recommended by the Clinical and Laboratory Standards Institute (CLSI).
Determination of minimum inhibitory concentrations
Minimum inhibitory concentrations (MICs) of the natural products and norfloxacin for S. marcescens were determined in triplicate using the broth microdilution method according to the CLSI. Briefly, serial 2-fold dilutions of the drugs at a starting concentration of 512 μg mL −1 were loaded into a 96-well microplate using Mueller-Hinton broth (MHB). Then the strain, at a density of about 5 × 10 5 cfu mL −1 in MHB was incubated with the drugs for a further 18-20 h at 28
• C. The MICs were defined as the lowest concentration inhibiting bacterial growth. Serratia marcescens ATCC 8100 was employed as control strain.
Checkerboard assay
The combinations of natural products and norfloxacin were evaluated in a 96-well microplate using the checkerboard method according to a previous report (Chen et al. 2014) . Briefly, serial concentrations of antimicrobial agents, after addition of 100 μL of inoculum, ranged from 2 μg mL −1 to 512 μg mL −1 for norfloxacin and from 8 μg mL −1 to 512 μg mL −1 for the natural products. Then 100 μL of inoculum was loaded per well at a concentration of 5 × 10 5 cfu mL −1 . The plates were further incubated at 28
• C for 18-20 h. The fractional inhibitory concentrations (FICs) were determined according to a previous report (Novy et al. 2011) . The fractional inhibitory concentration index (FICI) was calculated using the combined FICs of norfloxacin and natural products in each plate (European Committee for Antimicrobial Susceptibility Testing 2000). The results were classified as follows: synergistic effect (FICI ≤ 0.5); no interaction (0.5 < FICI < 4) and antagonistic effect (FICI > 4) (Drago et al. 2011 ).
Time-kill curves
The natural product with a synergistic effect was selected for the measurement of time-kill curves. The assay was performed as described by L. Drago (Drago et al. 2011) . The strain was cultured in Mueller-Hinton medium for 18-24 h and then the density adjusted to about 1 × 10 8 cfu mL −1 using a McFarland standard. The final concentration of the inoculum was diluted to 1 × 10 5 cfu mL −1 in the 5 ml final volume system. The concentrations of the agents in the tubes were 32 μg mL −1 norfloxacin, 128
μg mL −1 fisetin, and 32 μg mL −1 norfloxacin plus 128 μg mL
fisetin, which were determined by the MIC assay above. Then the mixtures were incubated at 37
• C for a further 48 h. Bacterial counts were performed every 12 h at 37
• C by incubating serial dilutions of the culture on MHB agar plates. The synergistic effect was defined as a 2 log 10 cfu mL −1 decrease when compared with the most active single agent at the same time point; antagonism was defined as a 2 log 10 cfu mL −1 increase when compared with the most active single agent; indifferent was defined as a change < 2 log 10 cfu mL −1 when compared with the most active single agent.
Statistical analysis
The differences in MICs between norfloxacin alone and the fisetin-norfloxacin combination were analyzed by Student's t-test with SPSS 14.0 statistical software (SPSS Inc., Chicago, IL, USA), and a P value less than 0.05 was considered to be statistically significant.
RESULTS
Identification of the bacterial strain
Only one bacterial strain was isolated from the liver of the diseased soft-shelled turtle. When the strain was cultured in LB medium at 37
• C, the medium showed pink colonies. The biochemical characterization results showed that the strain was identified as a S. marcescens strain with 99.5% phenotypic 
All data represent three independent experiments. identity (Table 1) . Moreover, the results of the 16S rRNA sequence analysis showed that the sequence shared 99% homology with typical strain ATCC 8100.
Antibiotic resistance
Most S. marcescens strains are reported as having resistance to several antibiotics (Yang et al. 2012) . We found that the strain we used here was resistant to most of the tested antibiotics (Table 2) and intermediate to ciprofloxacin and norfloxacin (Table 2) . No antibiotics were found among the tested agents to which this strain was susceptible (Table 2) .
Antimicrobial activities of single agents
The in vitro antimicrobial activities of norfloxacin and 10 natural products were determined by MIC. The results of the agents alone and the natural products combined with norfloxacin are listed in Table 3 . We found that the MIC value of norfloxacin could reach 64 μg mL −1 for the isolated strain, while the MIC values of the natural products could reach from 64 to 1024 μg mL −1 .
Checkerboard assay
To evaluate the synergistic effect of norfloxacin combined with natural products, checkerboard assays were performed and the FICI values were calculated for each agent. The FICI data are summarized in Table 3 . The FICI value of fisetin combined with norfloxacin could reach 0.14. This result reveals that fisetin combined with norfloxacin showed a good synergistic effect under our experimental conditions (Table 3 ). There was a significant decrease in MIC when norfloxacin alone was compared with the fisetin-norfloxacin combination (Student's t-test, P < 0.05). No antagonistic effect was observed in any of the tested agents.
Time-kill curves
To further confirm the synergistic effect of fisetin, we performed time-kill curves with norfloxacin alone or combined with fisetin using the isolated S. marcescens strain. As shown in Fig. 1 , the combination of fisetin could increase the killing activity of norfloxacin from 12 to 48 h. However, the synergy was only observed after 24 h. At the time point of 48 h, the yield of S. marcescens from the combination of fisetin and norfloxacin showed a 2.44 log 10 cfu mL −1 decrease compared with 32 μg mL −1 of norfloxacin only. The killing activity of norfloxacin could be significantly increased when combined with fisetin.
DISCUSSION
Ever since the first antibiotics were introduced for the treatment of bacterial infections, the development of novel antibiotics accompanied the spread of resistance around the world (Palumbi 2001) . Moreover, the decline in the identification of novel antibiotics leads us to the post-antibiotic era. There will be no available antibiotics for the treatment of bacterial infections in the future (Qiu et al. 2012) . In particular, the emergence The MIC values of natural products and norfloxacin (alone or in combination) against isolated S. marcescens strain.
Natural product name MIC of agents alone (μg mL −1 ) MIC in combination (μg mL −1 ) R e s u l t s of multi-resistant bacteria makes the battle even tougher; therefore the search for new tactics against these pathogens has never stopped. Chinese traditional herbs have been used for thousands of years in the treatment of infectious diseases; natural products extracted from Chinese traditional herbs are also used. Some of the natural products were previously reported to have synergistic activity when combined with antibiotics in the treatment of antibiotic-resistant strains (Novy et al. 2011) . Serratia marcescens was first identified as a non-pathogenic bacterium and widely used around the world as a bio-marker. In recent years it has been reported that S. marcescens could cause severe diseases both in humans and animals (Mills and Drew 1976; Korner et al. 1994) . Because of the emergence of multiresistant strains, the pursuit of new treatment to overcome the infections caused by S. marcescens is an important issue in clinics (Ishii et al. 2014) . In this paper, we isolated a multi-resistant S. marcescens strain from the livers of diseased soft-shelled turtles, never previously reported in this animal. According to the results of our susceptibility assay, we found the isolated strain was not sensitive to all the tested antibiotics. Aminoglycoside and quinolone antibiotics have shown good inhibitory activity against gram-negative strains. However, the strain in this study is resistant to all five tested aminoglycoside antibiotics and intermediary to two quinolone antibiotics. These results are different from the strain isolated from diseased Siberian sturgeons by Cao et al. (Cao et al. 2014) . Nevertheless, these results reveal that the resistance of the S. marcescens strain has become more severe. Although Cao et al. had reported that several herbal extracts could inhibit the growth of S. marcescens, the concentration was high and not suitable as a drug in aquaculture.
Synergistic strategies are one of the most important approaches for the treatment of infectious diseases caused by drug-resistant strains. Several natural products have been previously reported to have synergistic activities when combined with antibiotics (Drago et al. 2011; Chen et al. 2014) . Natural products combined with antibiotics can decrease the dosage of antibiotics, reduce the side-effects, enhance the antimicrobial activity and lower the drug resistance (Novy et al. 2011) . Moreover, natural products have been identified as being active against the expression and activity of virulence factors secreted by bacterial pathogens (Qiu et al. 2012; Dong et al. 2013a,b) . Fisetin was identified as an inhibitor of hemolysin secreted by Listeria monocytogenes (Wang et al. 2015) . Synergistic activity against S. marcescens has never been investigated. In this paper, we analyzed the interactions between 10 natural products and norfloxacin using a checkerboard method. According to the results, we found that fisetin had synergistic activity when combined with norfloxacin. The results were further verified by the time-kill curve assay. These results indicate that the fisetin-norfloxacin complex is a candidate for use against multi-resistant S. marcescens infections.
